|
|
42
|
|
|
A101X
|
|
|
LABETALOL 5MG/ML INJ (FSB)
|
|
|
LABETALOL
|
|
|
LABETALOL
|
|
|
20ML VIAL
|
|
|
B
|
|
|
4.43
|
|
|
4.43
|
|
|
5MG/ML
|
|
|
VIAL
|
|
|
0
|
|
|
|
|
|
FSB
|
|
|
FLAGSHIP BIOTECH
|
|
|
STO
|
|
|
BRYDEN STOKES LTD
|
|
|
|
|
|
|
|
|
2026-04-01
|
|
|
2028-03-31
|
|
|
No
|
|
|
No
|
|
|
|
|
|
0
|
|
|
N
|
|
|
2424
|
|
|
BETA ADRENERGIC BLOCKING AGENTS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
BETA ADRENERGIC BLOCKING AGENTS
|
|
|
2026-03-05
|